Forte Biosciences Inc. (FBRX)
7.75
-1.35 (-14.84%)
At close: Mar 03, 2025, 3:59 PM
7.68
-0.90%
After-hours: Mar 03, 2025, 04:00 PM EST
Forte Biosciences Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -31.48M | -13.88M | -21.71M | -46.49M | -4.07M | -48.95M | -38.93M | -33.48M | -23.06M |
Depreciation & Amortization | 9K | n/a | 36K | 54K | 11K | 625K | 292K | 255K | 232K |
Stock-Based Compensation | 3.28M | 4.01M | 4.21M | 956K | 35.71K | 6.87M | 4.45M | n/a | n/a |
Other Working Capital | -663K | 1.47M | 1.01M | -3.46M | 274.84K | 4.82M | 2.21M | 1.28M | 176K |
Other Non-Cash Items | -131K | 3.81M | 61K | 30.89M | -918K | 7.77M | 5.26M | 1.74M | 928K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 918K | -6.87M | -4.45M | n/a | n/a |
Change in Working Capital | -392K | 1.68M | 720K | -3.83M | 1.25M | 6.08M | 2.52M | 1.87M | 747K |
Operating Cash Flow | -28.71M | -8.19M | -16.68M | -18.42M | -2.77M | -34.47M | -31.13M | -29.54M | -21.04M |
Capital Expenditures | -88K | n/a | n/a | n/a | -161.6K | -1.97M | -655K | -525K | -231K |
Acquisitions | n/a | n/a | n/a | 3.58K | n/a | 2.22M | 20K | n/a | 15K |
Purchase of Investments | -9.96M | n/a | n/a | n/a | n/a | -70.75M | -70.8M | -23M | -59.87M |
Sales Maturities Of Investments | 10.1M | n/a | n/a | n/a | n/a | 68.52M | 43.73M | 48.09M | 35.16M |
Other Investing Acitivies | n/a | n/a | n/a | 3.58M | 42.32M | -2.22M | -27.05M | 25.09M | -24.7M |
Investing Cash Flow | 47K | n/a | n/a | 3.58M | -161.6K | -4.19M | -27.71M | 24.57M | -24.93M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 23.32M | 138K | 2.91M | 50.74M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 89K | 3.38M | 33.23M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -28K | 12K | -44K | -32K | 4.86M | -8.63M | n/a | -592K | -982K |
Financial Cash Flow | 24.68M | 7.24M | -44K | 66.67M | 4.86M | 43.54M | 89.26M | 2.33M | 49.92M |
Net Cash Flow | -3.98M | -944K | -16.72M | 51.83M | 1.92M | 4.88M | 30.42M | -2.64M | 3.95M |
Free Cash Flow | -28.79M | -8.19M | -16.68M | -18.42M | -2.93M | -36.44M | -31.79M | -30.06M | -21.27M |